Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph II, Efficacy and Safety Using Autologous Tumor Infiltrating Lymphocytes

Protocol: OSU-17059

Full Title

A Phase II, Multicenter Study to Evaluate the Efficacy and Safety Using Autologous Tumor Infiltrating Lymphocytes (LN-145) in Patients with Recurrent, Metastatic or Persistent Cervical Carcinoma

Gynecologic Cancers Cervical Cancer